Clinical Trials Browser

Phase 1/2 × perillyl alcohol × 1 year × Clear all

NCT02704858 2026-03-02

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

Phase 1/2 Recruiting

Glioblastoma